{
  "title": "M21-1, Part VIII, Subpart iii, Chapter 10 - Presumptive Service Connection (SC) for Coronavirus Disease (COVID-19)",
  "url": "https://www.knowva.ebenefits.va.gov/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000203897/M21-1-Part-VIII-Subpart-iii-Chapter-10-Presumptive-Service-Connection-SC-for-Coronavirus-Disease-COVID-19",
  "content": "<-- Previous Section\nNext Section -->\nOverview\nIn This Chapter\nThis chapter contains the following topics:\nTopic\nTopic Name\n1\nGeneral Information on Presumptive SC for COVID-19\n2\nQualifying Periods of Service for Presumptive SC for COVID-19\n3\nCOVID-19 Claims Intake\n4\nCOVID-19 Claims Development\n5\nCOVID-19 Examination Requests\n6\nCOVID-19 Rating Decisions\n1\n.\nGeneral Information on Presumptive SC for COVID-19\nIntroduction\nThis topic includes general information on presumptive SC for COVID-19, including\npresumption of SC for COVID-19\nnomenclature for COVID-19\napplicable theories of SC\ndefinition of symptoms of COVID-19\n, and\nmanifestation period\n.\nChange Date\nAugust 2, 2022\nVIII.iii.10.1.a\n.\nPresumption of SC for COVID-19\nEffective January 5, 2021,\n38 U.S.C. 1164\nestablished the presumption of service connection (SC) for Coronavirus disease (COVID-19).\nReference\n:  For more information on the establishment of the presumption of SC for COVID-19, see\nPublic Law (PL) 116-315, Section 4101\n, the\nJohnny Isakson and David P. Roe, M.D. Veterans Health Care and Benefits Improvement Act of 2020\n.\nVIII.iii.10.1.b\n.\nNomenclature for COVID-19\nA claim for SC for the following conditions should be construed as a claim for the same disease:\nnovel coronavirus\nCoronavirus\nsevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2\ncoronavirus disease, and\nCOVID-19.\nVIII.iii.10.1.c\n.\nApplicable Theories of SC\n38 U.S.C 1164\nprovides that if symptoms of COVID-19 manifest within a defined period for individuals with qualifying service, COVID-19 shall be presumed to have occurred during the qualifying period of duty.\nImportant\n:  While the law is specific to establishing SC on a presumptive basis, there is no preclusion to other avenues of entitlement, such as\ndirect SC under\n38 CFR 3.303\non the basis of aggravation under\n38 CFR 3.306\n, or\non a secondary basis under\n38 CFR 3.310\n.\nReference\n:  For more information on considering multiple theories of SC, see\nM21-1, Part II, Subpart iii, 1.A.2.e\n.\nVIII.iii.10.1.d\n.\nDefinition:  Symptoms of COVID-19\nSymptoms of COVID-19\nare defined as symptoms that competent medical evidence demonstrates are experienced by an individual and directly related to COVID-19.\nImportant\n:  For the most up-to-date list of known symptoms, refer to the Centers for Disease Control and Prevention’s  (CDC’s) COVID-19 website,\nSymptoms of COVID-19 | CDC\n.\nVIII.iii.10.1.e\n.\nManifestation Period\nThe manifestation period for development of symptoms or death due to COVID-19 is as follows:\nduring a qualifying period of duty, if that period was more than 48 continuous hours in duration, or\nwithin 14 days following the date of separation from a qualifying period of duty.\nReference\n:  For more information on the qualifying periods of duty for presumptive SC, see\n38 U.S.C. 1164(b) and (c)\n, and\nM21-1, Part VIII, Subpart iii, 10.A.2.a\n.\n2\n.\nQualifying Periods of Service for Presumptive SC for COVID-19\nIntroduction\nThis topic includes guidance on qualifying periods of service for presumptive SC for COVID-19, including\nqualifying period of service requirements\nrequired duration of service\n, and\ninactive duty for training (IADT) as qualifying service\n.\nChange Date\nAugust 2, 2022\nVIII.iii.10.2.a.\nQualifying Period of  Service Requirements\nQualifying service for presumptive SC for COVID-19 is\nactive duty from March 1, 2020, until January 5, 2024\nactive duty for training (ADT) under Title 10 or full-time National Guard duty (as defined in Section 101 of Title 10) under orders issued on or after March 13, 2020, until January 5, 2024, or\ncertain periods of inactive duty for training (IADT) during which COVID-19 is presumed to have been incurred occurring between March 13, 2020, and January 5, 2024.\nReferences\n:  For more information on\nconsidering certain periods of IADT as qualifying service, see\nM21-1, Part VIII, Subpart iii, 10.2.c\n, and\nverifying periods of ADT and IADT, see\nM21-1, Part III, Subpart i, 1.A.2.e\n.\nVIII.iii.10.2.b\n.\nRequired Duration of Service\nAs noted in\nM21-1, Part VIII, Subpart iii, 10.1.e\n, when COVID-19 symptoms develop\nduring\nan applicable qualifying period of service, the duty period must have been more than 48 hours for presumption to apply relative to exposure to COVID-19 during that period.\nWhen COVID-19 manifests within the 14 days following a qualifying period of service, there is no minimum length of service for the qualifying period.\nVIII.iii.10.2.c\n.\nIADT as Qualifying Service\nSC for COVID-19 may be established on a presumptive basis for certain periods of IADT.\n38 U.S.C. 1164(c)(2)\nprovides this authority by stating that benefits based on application of the presumptions will be paid as if the individual was a Veteran, without regard to whether the period would constitute active military, naval, air, or space service under\n10 U.S.C. 101\n.\nIADT occurring between March 13, 2020, and January 5, 2024, is qualifying service for consideration of presumptive SC only if a service member develops symptoms or tests positive for COVID-19\nduring a period of IADT, if the period of service was more than 48 continuous hours, or\nin the 14-day manifestation period following a period of IADT of any duration.\nNote\n:  A period of qualifying IADT service is considered\nactive service\nunder\n38 CFR 3.6\nonly\nwhen SC is established for a residual disability associated with the COVID-19 infection.\nReference\n:  For more information on the prohibition of direct SC for COVID-19 based on IADT service, see\nM21-1, Part VIII, Subpart iii, 10.6.c\n.\n3\n.\nCOVID-19 Claims Intake\nIntroduction\nThis topic contains information on intake procedures for claims for presumptive SC for COVID-19, including\nuse of the COVID-19 special issue indicator\n, and\nhandling allegations of COVID-19 exposure\n.\nChange Date\nAugust 2, 2022\nVIII.iii.10.3.a\n.\nUse of the COVID-19 Special Issue Indicator\nAppend the\nCOVID-19\nspecial issue indicator to each associated contention on the end product.\nReference\n:  For more information on the use of special issue indicators, see\nM21-4, Appendix E.2\n.\nVIII.iii.10.3.b\n.\nHandling Allegations of COVID-19 Exposure\nExposure to COVID-19, without association with an underlying disability, is not a substantially complete claim as required by\n38 CFR 3.160\n.\nFollow the procedures in\nM21-1, Part II, Subpart iii, 1.C.2.b and c\nfor handling allegations of exposure to COVID-19 without a claimed disability.\n4\n.\nCOVID-19 Claims Development\nIntroduction\nThis topic contains policies and procedures for COVID-19 claims development, including\nCOVID-19 claims development\n, and\nreferral to the rating activity\n.\nChange Date\nAugust 2, 2022\nVIII.iii.10.4.a\n.\nCOVID-19 Claims Development\nComplete development for claims for SC for COVID-19 in accordance with general development procedures.\nIf needed, ascertain COVID-19 residuals.  Follow the procedures in\nM21-1, Part III, Subpart i, 2.D.1.c\nto contact the claimant when it is unclear whether the individual is claiming residuals of COVID-19.\nVIII.iii.10.4.b\n.\nReferral to the Rating Activity\nWhen all required development is complete and all disability benefits questionnaires (DBQs) are received, including DBQs completed for residual conditions, refer the claim to the rating activity.\nReferences\n:  For more information on\nreferring claims to the rating activity after development is complete, see\nM21-1, Part V, Subpart i, 1.B.1.a\n, and\nrequesting examinations for claims for SC for COVID-19 and residuals, see\nM21-1, Part VIII, Subpart iii, 10.5\n.\n5\n.\nCOVID-19 Examination Requests\nIntroduction\nThis topic contains policies and procedures for requesting medical examinations for claims for SC for COVID-19, including\nevidence needed to request an examination\nrequesting medical opinions to confirm a COVID-19 diagnosis\n, and\nguidelines for examinations\n.\nChange Date\nAugust 2, 2022\nVIII.iii.10.5.a\n.\nEvidence Needed to Request an Examination\nSchedule any necessary medical examination(s) when the evidence shows a/an\nqualifying period of duty\ncompetent lay or medical evidence of a current disability or persistent or recurrent symptoms of a disability, and\nallegation of the onset of those symptoms during the manifestation period that is credible and consistent with all other facts of record.\nNotes\n:\nA positive COVID-19 test is not required before requesting an examination.\nFor claims based on ADT and IADT, treat the qualifying period of duty as active service for the purpose of scheduling an examination or medical opinion under\n38 CFR 3.159\n.\nReference\n:  For more information on the competency of lay testimony as it pertains to establishing a diagnosis of a condition, see\nM21-1, Part IV, Subpart i, 1.B.1.a and b\n, and\nJandreau v. Nicholson\n, 492 F.3d 1372 (Fed. Cir. 2007).\nVIII.iii.10.5.b\n.\nRequesting Medical Opinions to Confirm a COVID-19 Diagnosis\nRequest a medical opinion and examination (as needed) concerning whether a diagnosis of COVID-19 is warranted when the following conditions are present:\na claimant has qualifying service, and\nsymptoms arose during the applicable manifestation period, regardless of whether the condition was formally diagnosed, but there is question as to whether the symptoms experienced by the claimant are attributable to COVID-19.\nNote\n:  A medical opinion may also be needed if there is a question as to the date of manifestation of COVID-19.\nReference\n:  For more information on requesting medical opinions for cause of death, including COVID-19 related death, see\nM21-1, Part XII, Subpart i, 1.B.1.h\n.\nVIII.iii.10.5.c\n.\nGuidelines for Examinations\nFollow the guidelines below when an examination is needed.\nRequest the\nInfectious Diseases Disability Benefits Questionnaire\nfor all COVID-19-related claims, even if the record indicates that COVID-19 has resolved.\nRequest separate DBQs appropriate for the claimed residual conditions.\nNote on the examination request the date of any COVID-19 test(s) and the results.\nEnsure any specifically claimed COVID-19 residual condition is identified in the examination request so the examiner is fully aware of any residual condition(s) that must be addressed.\nIf the evidence indicates the claimed disability or symptoms may be associated with COVID-19, request a medical opinion as needed.\n6\n.\nCOVID-19 Rating Decisions\nIntroduction\nThis topic contains policies and procedures for rating decisions for claims for presumptive SC for COVID-19, including\npresumptive SC applicability\npresumptive vs. direct SC for COVID-19\nprohibition of direct SC for COVID-19 based on IADT\nconsidering presumptive vs. direct SC for COVID-19\nrebuttal of presumptive SC for COVID-19\n, and\neffective date considerations for presumptive SC for COVID-19\n.\nChange Date\nAugust 2, 2022\nVIII.iii.10.6.a\n.\nPresumptive SC Applicability\nSC may be established for residuals of COVID-19 on a presumptive basis if evidence supports symptoms or a positive test for COVID-19 within the defined manifestation period.\nReferences\n:  For more information on\nthe defined manifestation period, see\n38 U.S.C. 1164(a)(2)(A)\n, and\nM21-1, Part VIII, Subpart iii, 10.A.1.e\n, and\nrating considerations for evaluating COVID-19, see\nM21-1, Part V, Subpart iii, 3.6\n.\nVIII.iii.10.6.b\n.\nPresumptive vs. Direct SC for COVID-19\nAlthough\n38 U.S.C. 1164\nestablishes provisions for granting SC on a presumptive basis, SC for residuals of COVID-19 has been and continues to be available on a direct basis without regard to the presumptive provisions.\nAn in-service diagnosis of COVID-19 is sufficient to concede an in-service event for the purposes of establishing direct SC.  This applies even when the service records do not explicitly include the results of a COVID-19 test.\nIf evidence shows that chronic residuals of COVID-19 are related to service through a medical nexus, direct SC is warranted.\nImportant\n:  When SC for COVID-19 can be granted on a direct basis, default to direct SC and do not apply the presumptive provision\nexcept\nwhen presumptive SC allows for assignment of a more favorable effective date under\n38 CFR 3.114\n.\nException\n:  Direct SC is generally not available for COVID-19 incurred during a period of IADT, as discussed in\nM21-1, Part VIII, Subpart iii, 10.6.c\n.\nReference\n:  For more information on maximizing effective date determinations, see\nM21-1, Part V, Subpart ii, 4.A.1.i\n.\nVIII.iii.10.6.c\n.\nProhibition of Direct SC for COVID-19 Based on IADT\nAs provided in\n38 CFR 3.6(a)\n, IADT is considered active service only when the individual concerned was disabled or died from an\ninjury\nincurred or aggravated in the line of duty or from an acute myocardial infarction, a cardiac arrest, or a cerebrovascular accident.\nCOVID-19 is a\ndisease\n, not an\ninjury\n.  The incurrence of COVID-19 during a period of IADT does not provide a basis for establishing direct SC.\nException\n:  If the period of IADT is established as active service by virtue of the grant of SC for an injury or qualifying condition listed in\n38 CFR 3.6(a)\n, SC for COVID-19 would be evaluated under the standard principles for direct SC.\nReferences\n:  For more information on\nSC for a disability that results from administration of a COVID-19 vaccination during IADT, see\nM21-1, Part V, Subpart iii, 3.6.e\n, and\nadjudicating claims based on ADT and IADT, see\nM21-1, Part III, Subpart i, 1.A.2.k\n.\nVIII.iii.10.6.d\n.\nConsidering Presumptive vs. Direct SC for COVID-19\nRefer to the table below for guidance on determining whether to apply presumptive or direct SC provisions, when warranted, for COVID-19.\nIf COVID-19 becomes manifest ...\nThen consider entitlement to SC compensation on a ...\nduring a period of\nactive duty\ndirect basis.\nwithin the 14-day period after separating from\nactive duty\npresumptive basis.\na period of\nADT\ndirect basis.\nwithin the 14-day period after separating from\nADT\npresumptive basis.\na period of\nIADT\npresumptive basis.\nwithin the 14-day period after separating from\nIADT\npresumptive basis.\nException\n:  As noted in\nM21-1, Part VIII, Subpart iii, 10.6.b\n, when SC on a direct\nand\npresumptive basis may be supported, apply presumptive SC if it allows a more favorable outcome.\nVIII.iii.10.6.e\n.\nRebuttal of Presumptive SC for COVID-19\nConsider rebuttal of the presumption of SC when there is competent, credible, and persuasive medical evidence showing COVID-19 is more likely related to a non-service-related cause.\nReference\n:  For more information on the rebuttal of presumption, see\n38 U.S.C. 1113\n, and\nM21-1, Part V, Subpart ii, 2.B.1.d\n.\nVIII.iii.10.6.f\n.\nEffective Date Considerations for Presumptive SC for COVID-19\nThe general effective date rules for SC under\n38 CFR 3.400\napply when granting SC for the chronic residuals of COVID-19.  Consider the following important reminders when assigning effective dates:\nThe establishment of the presumptive provision is a liberalizing rule that warrants consideration of\n38 CFR 3.114\n.\nThe availability of direct SC for chronic residuals of COVID-19 incurred in or caused by a period of active duty or ADT is not based on a liberalizing provision.\nStatutory provisions for presumptive SC were added effective January 5, 2021.  Presumptive SC cannot be established prior to that date.\nReference\n:  For more information on effective dates for Dependency and Indemnity Compensation (DIC) when COVID-19 is associated with the cause of death, see\nM21-1 Part XII, Subpart i, 3.A.2\n.\n<-- Previous Section\nNext Section -->\nTo Top",
  "content_html": "<div class=\"article-content\">\n<div compile-custom=\"article.content\" ng-aria=\"articleContent\"><p class=\"ng-scope\"></p><p class=\"ng-scope\" style=\"text-align: right\"><span style=\"font-size: 11px\"><span style=\"font-family: arial , helvetica , sans-serif\"><a articleid=\"554400000202901\" articlename=\"M21-1, Part VIII, Subpart iii, Chapter 9, Section B - Processing Claims Based on Exposure to Specific Environmental or Military Occupational Hazards\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000202901/M21-1-Part-VIII-Subpart-iii-Chapter-9-Section-B-Processing-Claims-Based-on-Exposure-to-Specific-Environmental-or-Military-Occupational-Hazards\">&lt;-- Previous Section</a>  <a articleid=\"554400000177468\" articlename=\"M21-1, Part VIII, Subpart iv, Chapter 1, Section A - General Information and Development for Posttraumatic Stress Disorder (PTSD) Claims\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000177468/M21-1-Part-VIII-Subpart-iv-Chapter-1-Section-A-General-Information-and-Development-for-Posttraumatic-Stress-Disorder-PTSD-Claims\">Next Section --&gt;</a></span></span></p><p class=\"ng-scope\"><a id=\"top\" name=\"top\"><span style=\"font-size: 16px\"><span style=\"font-family: arial , helvetica , sans-serif\">Overview</span></span></a></p><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">In This Chapter</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"><p><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"> </span></span></p></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">This chapter contains the following topics: </span></span></div><div></div><table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" style=\"height: 0px; width: 495px; border-spacing: 0px; border-collapse: revert;\" width=\"495\"><tbody><tr><td style=\"width: 87px; padding: 0px;\"><div style=\"text-align: center\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong>Topic</strong></span></span></div></td><td style=\"width: 333px; padding: 0px;\"><div style=\"text-align: center\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong>Topic Name</strong></span></span></div></td></tr><tr><td style=\"width: 87px; padding: 0px;\"><div align=\"center\"><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">1</span></span></div></td><td style=\"width: 333px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a href=\"#1\" target=\"_self\">General Information on Presumptive SC for COVID-19 </a></span></span></div></td></tr><tr><td style=\"width: 87px; padding: 0px;\"><div align=\"center\"><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">2</span></span></div></td><td style=\"width: 333px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a href=\"#2\" target=\"_self\">Qualifying Periods of Service for Presumptive SC for COVID-19</a></span></span></div></td></tr><tr><td style=\"width: 87px; padding: 0px;\"><div align=\"center\"><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">3</span></span></div></td><td style=\"width: 333px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a href=\"#3\" target=\"_self\">COVID-19 Claims Intake</a></span></span></div></td></tr><tr><td style=\"width: 87px; text-align: center; padding: 0px;\"><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">4</span></span></td><td style=\"width: 333px; padding: 0px;\"><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a href=\"#4\" target=\"_self\">COVID-19 Claims Development</a></span></span></td></tr><tr><td style=\"width: 87px; text-align: center; padding: 0px;\"><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">5</span></span></td><td style=\"width: 333px; padding: 0px;\"><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a href=\"#5\" target=\"_self\">COVID-19 Examination Requests</a></span></span></td></tr><tr><td style=\"width: 87px; text-align: center; padding: 0px;\"><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">6</span></span></td><td style=\"width: 333px; padding: 0px;\"><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a href=\"#6\" target=\"_self\">COVID-19 Rating Decisions</a></span></span></td></tr></tbody></table><div></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"> </span></span><br/> </div><h2 class=\"ng-scope\"> <span style=\"font-size: 16px\"><span style=\"font-family: arial, helvetica, sans-serif\">1<a id=\"1\" name=\"1\">.</a>  General Information on Presumptive SC for COVID-19</span></span></h2><div class=\"ng-scope\"> <br/> </div><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Introduction</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">This topic includes general information on presumptive SC for COVID-19, including</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a href=\"#1a\" target=\"_self\">presumption of SC for COVID-19</a></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a href=\"#1b\" target=\"_self\">nomenclature for COVID-19</a></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a href=\"#1c\" target=\"_self\">applicable theories of SC</a></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a href=\"#1d\" target=\"_self\">definition of symptoms of COVID-19</a>, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a href=\"#1e\" target=\"_self\">manifestation period</a>. </span></span></div></li></ul></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Change Date</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">August 2, 2022</span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">VIII.iii.10.1.a<a id=\"1a\" name=\"1a\">.</a>  Presumption of SC for COVID-19</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">Effective January 5, 2021, <a href=\"https://www.law.cornell.edu/uscode/text/38/1164\" target=\"_blank\">38 U.S.C. 1164</a> established the presumption of service connection (SC) for Coronavirus disease (COVID-19).</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><b><i>Reference</i></b>:  For more information on the establishment of the presumption of SC for COVID-19, see <i>Public Law (PL) 116-315, Section 4101</i>, the <i>Johnny Isakson and David P. Roe, M.D. Veterans Health Care and Benefits Improvement Act of 2020</i>.  </span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">VIII.iii.10.1.b<a id=\"1b\" name=\"1b\">.</a>  Nomenclature for COVID-19 </span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">A claim for SC for the following conditions should be construed as a claim for the same disease:</span></span></div><ul><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">novel coronavirus</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">Coronavirus</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">coronavirus disease, and</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">COVID-19.</span> </span></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">VIII.iii.10.1.c<a id=\"1c\" name=\"1c\">.</a>  Applicable Theories of SC</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a href=\"https://www.law.cornell.edu/uscode/text/38/1164\" target=\"_blank\">38 U.S.C 1164</a> provides that if symptoms of COVID-19 manifest within a defined period for individuals with qualifying service, COVID-19 shall be presumed to have occurred during the qualifying period of duty.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><b><i>Important</i></b>:  While the law is specific to establishing SC on a presumptive basis, there is no preclusion to other avenues of entitlement, such as</span></span></div><ul><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">direct SC under <a href=\"https://www.ecfr.gov/current/title-38/chapter-I/part-3/subpart-A/subject-group-ECFR39056aee4e9ff13/section-3.303\" target=\"_blank\">38 CFR 3.303</a></span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">on the basis of aggravation under <a href=\"https://www.ecfr.gov/current/title-38/chapter-I/part-3/subpart-A/subject-group-ECFR39056aee4e9ff13/section-3.306\" target=\"_blank\">38 CFR 3.306</a>, or</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">on a secondary basis under <a href=\"https://www.ecfr.gov/current/title-38/chapter-I/part-3/subpart-A/subject-group-ECFR39056aee4e9ff13/section-3.310\" target=\"_blank\">38 CFR 3.310</a>. </span></span></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><b><i><span style=\"color: black\">Reference</span></i></b><span style=\"color: black\">:  For more information on considering multiple theories of SC, see <a articleid=\"554400000174869\" articlename=\"M21-1, Part II, Subpart iii, Chapter 1, Section A - Applications for Benefits\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000174869/M21-1-Part-II-Subpart-iii-Chapter-1-Section-A-Applications-for-Benefits\">M21-1, Part II, Subpart iii, 1.A.2.e</a>.</span></span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">VIII.iii.10.1.d<a id=\"1d\" name=\"1d\">.</a>  Definition:  Symptoms of COVID-19</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><i>Symptoms of COVID-19</i> are defined as symptoms that competent medical evidence demonstrates are experienced by an individual and directly related to COVID-19.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><b><i>Important</i></b>:  For the most up-to-date list of known symptoms, refer to the Centers for Disease Control and Prevention’s  (CDC’s) COVID-19 website, <a href=\"https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html\" target=\"_blank\">Symptoms of COVID-19 | CDC</a>.</span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">VIII.iii.10.1.e<a id=\"1e\" name=\"1e\">.</a>  Manifestation Period</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">The manifestation period for development of symptoms or death due to COVID-19 is as follows:</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">during a qualifying period of duty, if that period was more than 48 continuous hours in duration, or</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">within 14 days following the date of separation from a qualifying period of duty.</span></span></div></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><b><i>Reference</i></b>:  For more information on the qualifying periods of duty for presumptive SC, see</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a href=\"https://www.law.cornell.edu/uscode/text/38/1164\" target=\"_blank\">38 U.S.C. 1164(b) and (c)</a>, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a href=\"#2a\" target=\"_self\">M21-1, Part VIII, Subpart iii, 10.A.2.a</a>.</span></span></div></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"> </span></span></div><div class=\"ng-scope\"> <br/> </div><h2 class=\"ng-scope\"><span style=\"font-size: 16px\"><span style=\"font-family: arial , helvetica , sans-serif\">2<a id=\"2\" name=\"2\">.</a>  Qualifying Periods of Service for Presumptive SC for COVID-19</span></span><br/> </h2><div class=\"ng-scope\"></div><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Introduction</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">This topic includes guidance on qualifying periods of service for presumptive SC for COVID-19, including</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a href=\"#2a\" target=\"_self\">qualifying period of service requirements</a></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a href=\"#2b\" target=\"_self\">required duration of service</a>, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a href=\"#2c\" target=\"_self\">inactive duty for training (IADT) as qualifying service</a>. </span></span></div></li></ul></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Change Date</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">August 2, 2022</span></span></div></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">VIII.iii.10.2.a.<a id=\"2a\" name=\"2a\"> </a> Qualifying Period of  Service Requirements</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">Qualifying service for presumptive SC for COVID-19 is</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">active duty from March 1, 2020, until January 5, 2024</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">active duty for training (ADT) under Title 10 or full-time National Guard duty (as defined in Section 101 of Title 10) under orders issued on or after March 13, 2020, until January 5, 2024, or</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">certain periods of inactive duty for training (IADT) during which COVID-19 is presumed to have been incurred occurring between March 13, 2020, and January 5, 2024.</span></span></div></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><b><i>References</i></b>:  For more information on</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">considering certain periods of IADT as qualifying service, see <a href=\"#2c\" target=\"_self\">M21-1, Part VIII, Subpart iii, 10.2.c</a>, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">verifying periods of ADT and IADT, see <a articleid=\"554400000181424\" articlename=\"M21-1, Part III, Subpart i, Chapter 1, Section A - Establishing Veteran Status\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000181424/M21-1-Part-III-Subpart-i-Chapter-1-Section-A-Establishing-Veteran-Status\">M21-1, Part III, Subpart i, 1.A.2.e</a>.</span></span></div></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">VIII.iii.10.2.b<a id=\"2b\" name=\"2b\">.</a>  Required Duration of Service</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">As noted in <a href=\"#1e\" target=\"_self\">M21-1, Part VIII, Subpart iii, 10.1.e</a>, when COVID-19 symptoms develop <b><i>during</i></b> an applicable qualifying period of service, the duty period must have been more than 48 hours for presumption to apply relative to exposure to COVID-19 during that period.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">When COVID-19 manifests within the 14 days following a qualifying period of service, there is no minimum length of service for the qualifying period. </span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">VIII.iii.10.2.c<a id=\"2c\" name=\"2c\">.</a>  IADT as Qualifying Service</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">SC for COVID-19 may be established on a presumptive basis for certain periods of IADT.  <a href=\"https://www.law.cornell.edu/uscode/text/38/1164\" target=\"_blank\">38 U.S.C. 1164(c)(2)</a> provides this authority by stating that benefits based on application of the presumptions will be paid as if the individual was a Veteran, without regard to whether the period would constitute active military, naval, air, or space service under <a href=\"https://www.law.cornell.edu/uscode/text/10/101\" target=\"_blank\">10 U.S.C. 101</a>. </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">IADT occurring between March 13, 2020, and January 5, 2024, is qualifying service for consideration of presumptive SC only if a service member develops symptoms or tests positive for COVID-19</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">during a period of IADT, if the period of service was more than 48 continuous hours, or</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">in the 14-day manifestation period following a period of IADT of any duration.</span></span></div></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><b><i>Note</i></b>:  A period of qualifying IADT service is considered <i>active service</i> under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=5dea2e5ae38d4f4810bf7ca791a5efee&amp;node=se38.1.3_16&amp;rgn=div8\" target=\"_blank\">38 CFR 3.6</a> <i>only</i> when SC is established for a residual disability associated with the COVID-19 infection. </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><b><i>Reference</i></b>:  For more information on the prohibition of direct SC for COVID-19 based on IADT service, see <a href=\"#6c\" target=\"_self\">M21-1, Part VIII, Subpart iii, 10.6.c</a>.</span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><div class=\"ng-scope\" style=\"margin-left: 85pt\"></div><div class=\"ng-scope\" style=\"margin-left: 85pt\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"> </span></span></div><div class=\"ng-scope\"> <br/> </div><h2 class=\"ng-scope\"><span style=\"font-size: 16px\"><span style=\"font-family: arial , helvetica , sans-serif\">3<a id=\"3\" name=\"3\">.</a>  COVID-19 Claims Intake</span></span><br/><br/> </h2><div class=\"ng-scope\"></div><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Introduction</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">This topic contains information on intake procedures for claims for presumptive SC for COVID-19, including</span></span></div><ul><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a href=\"#3a\" target=\"_self\">use of the COVID-19 special issue indicator</a>, and</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a href=\"#3b\" target=\"_self\">handling allegations of COVID-19 exposure</a>. </span></span></li></ul></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Change Date</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">August 2, 2022</span></span></div></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">VIII.iii.10.3.a<a id=\"3a\" name=\"3a\">.</a>  Use of the COVID-19 Special Issue Indicator</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">Append the <em>COVID-19</em> special issue indicator to each associated contention on the end product.</span></span></div><div></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><em><strong>Reference</strong></em>:  For more information on the use of special issue indicators, see <a articleid=\"554400000179710\" articlename=\"Appendix E. Index of Corporate Flashes and Special Issues\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000179710/Appendix-E-Index-of-Corporate-Flashes-and-Special-Issues\">M21-4, Appendix E.2</a>.</span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-family: Arial, Helvetica, sans-serif\"><span style=\"font-size: 14px\">VIII.iii.10.3.b<a id=\"3b\" name=\"3b\">.</a>  Handling Allegations of COVID-19 Exposure</span> </span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">Exposure to COVID-19, without association with an underlying disability, is not a substantially complete claim as required by <a href=\"https://www.ecfr.gov/current/title-38/chapter-I/part-3/subpart-A/subject-group-ECFR7629a1b1e9bf6f8/section-3.160\" target=\"_blank\">38 CFR 3.160</a>. </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">Follow the procedures in <a articleid=\"554400000174872\" articlename=\"M21-1, Part II, Subpart iii, Chapter 1, Section C - Screening Applications for Substantial Completeness and Notification Requirements\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000174872/M21-1-Part-II-Subpart-iii-Chapter-1-Section-C-Screening-Applications-for-Substantial-Completeness-and-Notification-Requirements\">M21-1, Part II, Subpart iii, 1.C.2.b and c</a> for handling allegations of exposure to COVID-19 without a claimed disability.</span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><div class=\"ng-scope\"> <br/> </div><h2 class=\"ng-scope\"><span style=\"font-size: 16px\"><span style=\"font-family: arial , helvetica , sans-serif\">4<a id=\"4\" name=\"4\">.</a>  COVID-19 Claims Development</span></span></h2><div class=\"ng-scope\"> <br/> </div><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Introduction</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">This topic contains policies and procedures for COVID-19 claims development, including</span></span></div><ul><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a href=\"#4a\" target=\"_self\">COVID-19 claims development</a>, and</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a href=\"#4b\" target=\"_self\">referral to the rating activity</a>.</span></span></li></ul></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Change Date</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">August 2, 2022</span></span></div></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">VIII.iii.10.4.a<a id=\"4a\" name=\"4a\">.</a>  COVID-19 Claims Development</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">Complete development for claims for SC for COVID-19 in accordance with general development procedures. </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">If needed, ascertain COVID-19 residuals.  Follow the procedures in <a articleid=\"554400000033257\" articlename=\"M21-1, Part III, Subpart i, Chapter 2, Section D - Evidence Requested From the Claimant\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000033257/M21-1-Part-III-Subpart-i-Chapter-2-Section-D-Evidence-Requested-From-the-Claimant\">M21-1, Part III, Subpart i, 2.D.1.c</a> to contact the claimant when it is unclear whether the individual is claiming residuals of COVID-19.</span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">VIII.iii.10.4.b<a id=\"4b\" name=\"4b\">.</a>  Referral to the Rating Activity</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">When all required development is complete and all disability benefits questionnaires (DBQs) are received, including DBQs completed for residual conditions, refer the claim to the rating activity.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><b><i>References</i></b>:  For more information on</span></span></div><ul><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">referring claims to the rating activity after development is complete, see <a articleid=\"554400000180478\" articlename=\"M21-1, Part V, Subpart i, Chapter 1, Section B - Referrals to the Rating Activity\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180478/M21-1-Part-V-Subpart-i-Chapter-1-Section-B-Referrals-to-the-Rating-Activity\">M21-1, Part V, Subpart i, 1.B.1.a</a>, and</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">requesting examinations for claims for SC for COVID-19 and residuals, see <a href=\"#5\" target=\"_self\">M21-1, Part VIII, Subpart iii, 10.5</a>.</span></span></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><div class=\"ng-scope\"> <br/> </div><h2 class=\"ng-scope\"><span style=\"font-size: 16px\"><span style=\"font-family: arial , helvetica , sans-serif\">5<a id=\"5\" name=\"5\">.</a>  COVID-19 Examination Requests</span></span></h2><div class=\"ng-scope\"> <br/> </div><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Introduction</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">This topic contains policies and procedures for requesting medical examinations for claims for SC for COVID-19, including</span></span></div><ul><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a href=\"#5a\" target=\"_self\">evidence needed to request an examination</a></span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a href=\"#5b\" target=\"_self\">requesting medical opinions to confirm a COVID-19 diagnosis</a>, and</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a href=\"#5c\" target=\"_self\">guidelines for examinations</a>.</span></span></li></ul></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Change Date</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">August 2, 2022</span></span></div></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">VIII.iii.10.5.a<a id=\"5a\" name=\"5a\">.</a>  Evidence Needed to Request an Examination</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">Schedule any necessary medical examination(s) when the evidence shows a/an</span></span></div><ul><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">qualifying period of duty</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">competent lay or medical evidence of a current disability or persistent or recurrent symptoms of a disability, and</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">allegation of the onset of those symptoms during the manifestation period that is credible and consistent with all other facts of record.</span></span></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><b><i>Notes</i></b>: </span></span></div><ul><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">A positive COVID-19 test is not required before requesting an examination.</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">For claims based on ADT and IADT, treat the qualifying period of duty as active service for the purpose of scheduling an examination or medical opinion under <a href=\"https://www.ecfr.gov/current/title-38/chapter-I/part-3/subpart-A/subject-group-ECFR7629a1b1e9bf6f8/section-3.159\" target=\"_blank\">38 CFR 3.159</a>.</span></span></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><b><i>Reference</i></b>:  For more information on the competency of lay testimony as it pertains to establishing a diagnosis of a condition, see</span></span></div><ul><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a articleid=\"554400000180495\" articlename=\"M21-1, Part IV, Subpart i, Chapter 1, Section B - Evidentiary Standards for Finding an Examination or Opinion Necessary\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180495/M21-1-Part-IV-Subpart-i-Chapter-1-Section-B-Evidentiary-Standards-for-Finding-an-Examination-or-Opinion-Necessary\">M21-1, Part IV, Subpart i, 1.B.1.a and b</a>, and</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><i><a articleid=\"554400000014836\" articlename=\"Jandreau v. Nicholson, Jul 3, 2007, 492 F.3d 1372\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014836/Jandreau-v-Nicholson-Jul-3-2007-492-F3d-1372\">Jandreau v. Nicholson</a></i>, 492 F.3d 1372 (Fed. Cir. 2007).</span></span></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">VIII.iii.10.5.b<a id=\"5b\" name=\"5b\">.</a>  Requesting Medical Opinions to Confirm a COVID-19 Diagnosis</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">Request a medical opinion and examination (as needed) concerning whether a diagnosis of COVID-19 is warranted when the following conditions are present:</span></span></div><ul><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">a claimant has qualifying service, and</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">symptoms arose during the applicable manifestation period, regardless of whether the condition was formally diagnosed, but there is question as to whether the symptoms experienced by the claimant are attributable to COVID-19.</span></span></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><b><i>Note</i></b>:  A medical opinion may also be needed if there is a question as to the date of manifestation of COVID-19. </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><b><i>Reference</i></b>:  For more information on requesting medical opinions for cause of death, including COVID-19 related death, see <a articleid=\"554400000175203\" articlename=\"M21-1, Part XII, Subpart i, Chapter 1, Section B - Common Dependency and Indemnity Compensation (DIC) Processing Issues\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000175203/M21-1-Part-XII-Subpart-i-Chapter-1-Section-B-Common-Dependency-and-Indemnity-Compensation-DIC-Processing-Issues\">M21-1, Part XII, Subpart i, 1.B.1.h</a>.</span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">VIII.iii.10.5.c<a id=\"5c\" name=\"5c\">.</a>  Guidelines for Examinations</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">Follow the guidelines below when an examination is needed.</span></span></div><ul><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">Request the <i>Infectious Diseases Disability Benefits Questionnaire</i> for all COVID-19-related claims, even if the record indicates that COVID-19 has resolved.</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">Request separate DBQs appropriate for the claimed residual conditions.</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">Note on the examination request the date of any COVID-19 test(s) and the results.</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">Ensure any specifically claimed COVID-19 residual condition is identified in the examination request so the examiner is fully aware of any residual condition(s) that must be addressed.</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">If the evidence indicates the claimed disability or symptoms may be associated with COVID-19, request a medical opinion as needed.  </span></span></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><div class=\"ng-scope\"> <br/> </div><h2 class=\"ng-scope\"><span style=\"font-size: 16px\"><span style=\"font-family: arial , helvetica , sans-serif\">6<a id=\"6\" name=\"6\">.</a> COVID-19 Rating Decisions</span></span></h2><div class=\"ng-scope\"> <br/> </div><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Introduction</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">This topic contains policies and procedures for rating decisions for claims for presumptive SC for COVID-19, including</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a href=\"#6a\" target=\"_self\">presumptive SC applicability</a></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a href=\"#6b\" target=\"_self\">presumptive vs. direct SC for COVID-19</a></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a href=\"#6c\" target=\"_self\">prohibition of direct SC for COVID-19 based on IADT</a></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a href=\"#6d\" target=\"_self\">considering presumptive vs. direct SC for COVID-19</a></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a href=\"#6e\" target=\"_self\">rebuttal of presumptive SC for COVID-19</a>, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a href=\"#6f\" target=\"_self\">effective date considerations for presumptive SC for COVID-19</a>.</span></span></div></li></ul></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Change Date</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">August 2, 2022</span></span></div></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">VIII.iii.10.6.a<a id=\"6a\" name=\"6a\">.</a>  Presumptive SC Applicability</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">SC may be established for residuals of COVID-19 on a presumptive basis if evidence supports symptoms or a positive test for COVID-19 within the defined manifestation period. </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><b><i>References</i></b>:  For more information on</span></span></div><ul><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">the defined manifestation period, see</span></span><ul><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a href=\"https://www.law.cornell.edu/uscode/text/38/1164\" target=\"_blank\">38 U.S.C. 1164(a)(2)(A)</a>, and</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a href=\"#1e\" target=\"_self\">M21-1, Part VIII, Subpart iii, 10.A.1.e</a>, and</span></span></li></ul></li><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">rating considerations for evaluating COVID-19, see <a articleid=\"554400000014467\" articlename=\"M21-1, Part V, Subpart iii, Chapter 3 - Infectious Diseases, Immune Disorders, and Nutritional Deficiencies\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014467/M21-1-Part-V-Subpart-iii-Chapter-3-Infectious-Diseases-Immune-Disorders-and-Nutritional-Deficiencies\">M21-1, Part V, Subpart iii, 3.6</a>.</span></span></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">VIII.iii.10.6.b<a id=\"6b\" name=\"6b\">.</a>  Presumptive vs. Direct SC for COVID-19</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">Although <a href=\"https://www.law.cornell.edu/uscode/text/38/1164\" target=\"_blank\">38 U.S.C. 1164</a> establishes provisions for granting SC on a presumptive basis, SC for residuals of COVID-19 has been and continues to be available on a direct basis without regard to the presumptive provisions. </span></span></div><ul><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">An in-service diagnosis of COVID-19 is sufficient to concede an in-service event for the purposes of establishing direct SC.  This applies even when the service records do not explicitly include the results of a COVID-19 test.</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">If evidence shows that chronic residuals of COVID-19 are related to service through a medical nexus, direct SC is warranted.</span></span></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><b><i>Important</i></b>:  When SC for COVID-19 can be granted on a direct basis, default to direct SC and do not apply the presumptive provision <i>except</i> when presumptive SC allows for assignment of a more favorable effective date under <a href=\"https://www.ecfr.gov/current/title-38/chapter-I/part-3/subpart-A/subject-group-ECFR63da83ba671b92b/section-3.114\" target=\"_blank\">38 CFR 3.114</a>.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><b><i>Exception</i></b>:  Direct SC is generally not available for COVID-19 incurred during a period of IADT, as discussed in <a href=\"#6c\" target=\"_self\">M21-1, Part VIII, Subpart iii, 10.6.c</a>.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><b><i>Reference</i></b><span style=\"color: black\">:  For more information on maximizing effective date determinations, see <a articleid=\"554400000180492\" articlename=\"M21-1, Part V, Subpart ii, Chapter 4, Section A - Effective Dates\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180492/M21-1-Part-V-Subpart-ii-Chapter-4-Section-A-Effective-Dates\">M21-1, Part V, Subpart ii, 4.A.1.i</a>. </span></span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">VIII.iii.10.6.c<a id=\"6c\" name=\"6c\">.</a>  Prohibition of Direct SC for COVID-19 Based on IADT</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">As provided in <a href=\"https://www.ecfr.gov/current/title-38/chapter-I/part-3/subpart-A/subject-group-ECFRf5fe31f49d4f511/section-3.6\" target=\"_blank\">38 CFR 3.6(a)</a>, IADT is considered active service only when the individual concerned was disabled or died from an <i>injury</i> incurred or aggravated in the line of duty or from an acute myocardial infarction, a cardiac arrest, or a cerebrovascular accident.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">COVID-19 is a <i>disease</i>, not an <i>injury</i>.  The incurrence of COVID-19 during a period of IADT does not provide a basis for establishing direct SC. </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><b><i>Exception</i></b>:  If the period of IADT is established as active service by virtue of the grant of SC for an injury or qualifying condition listed in <a href=\"https://www.ecfr.gov/current/title-38/chapter-I/part-3/subpart-A/subject-group-ECFRf5fe31f49d4f511/section-3.6\" target=\"_blank\">38 CFR 3.6(a)</a>, SC for COVID-19 would be evaluated under the standard principles for direct SC.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><b><i>References</i></b>:  For more information on</span></span></div><ul><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">SC for a disability that results from administration of a COVID-19 vaccination during IADT, see <a articleid=\"554400000014467\" articlename=\"M21-1, Part V, Subpart iii, Chapter 3 - Infectious Diseases, Immune Disorders, and Nutritional Deficiencies\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014467/M21-1-Part-V-Subpart-iii-Chapter-3-Infectious-Diseases-Immune-Disorders-and-Nutritional-Deficiencies\">M21-1, Part V, Subpart iii, 3.6.e</a>, and</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">adjudicating claims based on ADT and IADT, see <a articleid=\"554400000181424\" articlename=\"M21-1, Part III, Subpart i, Chapter 1, Section A - Establishing Veteran Status\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000181424/M21-1-Part-III-Subpart-i-Chapter-1-Section-A-Establishing-Veteran-Status\">M21-1, Part III, Subpart i, 1.A.2.k</a>.</span></span></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">VIII.iii.10.6.d<a id=\"6d\" name=\"6d\">.</a>  Considering Presumptive vs. Direct SC for COVID-19</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">Refer to the table below for guidance on determining whether to apply presumptive or direct SC provisions, when warranted, for COVID-19.</span> </span></div><div></div><table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-spacing: 0px; border-collapse: revert;\" summary=\"This is an if-then table.  Column 1 contains the criteria and column 2 contains the guidance on determining whether to apply presumptive or direct SC provisions, when warranted, for COVID-19. \" width=\"510\"><thead><tr><th scope=\"col\" style=\"padding: 0px;\"><div style=\"text-align: left\"><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><b>If COVID-19 becomes manifest ...</b></span></span></div></th><th scope=\"col\" style=\"padding: 0px;\"><div style=\"text-align: left\"><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><b>Then consider entitlement to SC compensation on a ...</b></span></span></div></th></tr></thead><tbody><tr><td style=\"padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">during a period of <b><i>active duty</i></b></span></span></div></td><td style=\"padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">direct basis.</span></span></div></td></tr><tr><td style=\"padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">within the 14-day period after separating from <b><i>active duty</i></b></span></span></div></td><td style=\"padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">presumptive basis.</span></span></div></td></tr><tr><td style=\"padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">a period of <b><i>ADT</i></b></span></span></div></td><td style=\"padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">direct basis.</span></span></div></td></tr><tr><td style=\"padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">within the 14-day period after separating from <b><i>ADT</i></b></span></span></div></td><td style=\"padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">presumptive basis.</span></span></div></td></tr><tr><td style=\"padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">a period of <b><i>IADT</i></b></span></span></div></td><td style=\"padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">presumptive basis.</span></span></div></td></tr><tr><td style=\"padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">within the 14-day period after separating from <b><i>IADT</i></b></span></span></div></td><td style=\"padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">presumptive basis.</span></span></div></td></tr></tbody></table><div></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><b><i>Exception</i></b>:  As noted in <a href=\"#6b\" target=\"_self\">M21-1, Part VIII, Subpart iii, 10.6.b</a>, when SC on a direct <i>and</i> presumptive basis may be supported, apply presumptive SC if it allows a more favorable outcome.</span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">VIII.iii.10.6.e<a id=\"6e\" name=\"6e\">.</a>  Rebuttal of Presumptive SC for COVID-19</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">Consider rebuttal of the presumption of SC when there is competent, credible, and persuasive medical evidence showing COVID-19 is more likely related to a non-service-related cause.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><b><i>Reference</i></b>:  For more information on the rebuttal of presumption, see</span></span></div><ul><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a href=\"https://www.law.cornell.edu/uscode/text/38/1113\" target=\"_blank\">38 U.S.C. 1113</a>, and</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a articleid=\"554400000180482\" articlename=\"M21-1, Part V, Subpart ii, Chapter 2, Section B - Presumptive Service Connection (SC)\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180482/M21-1-Part-V-Subpart-ii-Chapter-2-Section-B-Presumptive-Service-Connection-SC\">M21-1, Part V, Subpart ii, 2.B.1.d</a>.</span></span></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">VIII.iii.10.6.f<a id=\"6f\" name=\"6f\">.</a>  Effective Date Considerations for Presumptive SC for COVID-19</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">The general effective date rules for SC under <a href=\"https://www.ecfr.gov/current/title-38/chapter-I/part-3/subpart-A/subject-group-ECFR429f47d98271c40/section-3.400\" target=\"_blank\">38 CFR 3.400</a> apply when granting SC for the chronic residuals of COVID-19.  Consider the following important reminders when assigning effective dates:</span></span></div><ul><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">The establishment of the presumptive provision is a liberalizing rule that warrants consideration of <a href=\"https://www.ecfr.gov/current/title-38/chapter-I/part-3/subpart-A/subject-group-ECFR63da83ba671b92b/section-3.114\" target=\"_blank\">38 CFR 3.114</a>.</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">The availability of direct SC for chronic residuals of COVID-19 incurred in or caused by a period of active duty or ADT is not based on a liberalizing provision. </span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">Statutory provisions for presumptive SC were added effective January 5, 2021.  Presumptive SC cannot be established prior to that date.</span></span></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><b><i>Reference</i></b>:  For more information on effective dates for Dependency and Indemnity Compensation (DIC) when COVID-19 is associated with the cause of death, see <a articleid=\"554400000175209\" articlename=\"M21-1, Part XII, Subpart i, Chapter 3, Section A - Dependency and Indemnity Compensation (DIC) Initial Authorization Issues\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000175209/M21-1-Part-XII-Subpart-i-Chapter-3-Section-A-Dependency-and-Indemnity-Compensation-DIC-Initial-Authorization-Issues\">M21-1 Part XII, Subpart i, 3.A.2</a>.</span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><p class=\"ng-scope\" style=\"text-align: right\"><span style=\"font-size: 11px\"><span style=\"font-family: arial , helvetica , sans-serif\"><a articleid=\"554400000202901\" articlename=\"M21-1, Part VIII, Subpart iii, Chapter 9, Section B - Processing Claims Based on Exposure to Specific Environmental or Military Occupational Hazards\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000202901/M21-1-Part-VIII-Subpart-iii-Chapter-9-Section-B-Processing-Claims-Based-on-Exposure-to-Specific-Environmental-or-Military-Occupational-Hazards\">&lt;-- Previous Section</a>  <a articleid=\"554400000177468\" articlename=\"M21-1, Part VIII, Subpart iv, Chapter 1, Section A - General Information and Development for Posttraumatic Stress Disorder (PTSD) Claims\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000177468/M21-1-Part-VIII-Subpart-iv-Chapter-1-Section-A-General-Information-and-Development-for-Posttraumatic-Stress-Disorder-PTSD-Claims\">Next Section --&gt;</a></span></span></p><p class=\"ng-scope\" style=\"text-align: left\"><span style=\"font-family: arial , helvetica , sans-serif\"><span style=\"font-size: 11px\"><a href=\"#top\" target=\"_self\">To Top</a></span></span></p><p class=\"ng-scope\"></p></div>\n</div>",
  "external_links": [
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=5dea2e5ae38d4f4810bf7ca791a5efee&node=se38.1.3_16&rgn=div8",
    "https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html",
    "https://www.ecfr.gov/current/title-38/chapter-I/part-3/subpart-A/subject-group-ECFR39056aee4e9ff13/section-3.303",
    "https://www.ecfr.gov/current/title-38/chapter-I/part-3/subpart-A/subject-group-ECFR39056aee4e9ff13/section-3.306",
    "https://www.ecfr.gov/current/title-38/chapter-I/part-3/subpart-A/subject-group-ECFR39056aee4e9ff13/section-3.310",
    "https://www.ecfr.gov/current/title-38/chapter-I/part-3/subpart-A/subject-group-ECFR429f47d98271c40/section-3.400",
    "https://www.ecfr.gov/current/title-38/chapter-I/part-3/subpart-A/subject-group-ECFR63da83ba671b92b/section-3.114",
    "https://www.ecfr.gov/current/title-38/chapter-I/part-3/subpart-A/subject-group-ECFR7629a1b1e9bf6f8/section-3.159",
    "https://www.ecfr.gov/current/title-38/chapter-I/part-3/subpart-A/subject-group-ECFR7629a1b1e9bf6f8/section-3.160",
    "https://www.ecfr.gov/current/title-38/chapter-I/part-3/subpart-A/subject-group-ECFRf5fe31f49d4f511/section-3.6",
    "https://www.law.cornell.edu/uscode/text/10/101",
    "https://www.law.cornell.edu/uscode/text/38/1113",
    "https://www.law.cornell.edu/uscode/text/38/1164"
  ],
  "scraped_at": "2025-06-16T23:00:37.459997",
  "next_section": "https://www.knowva.ebenefits.va.gov/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000177468/M21-1-Part-VIII-Subpart-iv-Chapter-1-Section-A-General-Information-and-Development-for-Posttraumatic-Stress-Disorder-PTSD-Claims"
}